Omixon acquires Organ Monitoring Group BV
Omixon to commercialize a cell-free DNA assay for transplant monitoring developed and validated by a transplant physician
Source: einnews.com
Stay updated with breaking news from Attila Berces. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Omixon to commercialize a cell-free DNA assay for transplant monitoring developed and validated by a transplant physician